$CTXR News Article - Citius Pharmaceuticals, Inc.
Post# of 47
(Total Views: 186)
Posted On: 09/28/2022 10:35:54 AM
$CTXR News Article - Citius Pharmaceuticals, Inc. Submits Biologics License Application to the U.S. Food and Drug Administration for Denileukin Diftitox for the Treatment of Patients with Persistent or Recurrent Cutaneous T-Cell Lymphoma https://marketwirenews.com/news-releases/citi...88519.html
(0)
(0)Citius Pharmaceuticals Inc. (CTXR) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼